CRIS Current Research Information System

MIGLIOLI, MARIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 3.320
NA - Nord America 2.688
EU - Europa 1.714
SA - Sud America 270
AF - Africa 157
OC - Oceania 2
Totale 8.151
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.646
SG - Singapore 1.032
VN - Vietnam 814
CN - Cina 712
HK - Hong Kong 352
SE - Svezia 289
GB - Regno Unito 278
IT - Italia 237
DE - Germania 226
BR - Brasile 214
FR - Francia 130
RU - Federazione Russa 108
IN - India 97
IE - Irlanda 88
NL - Olanda 84
UA - Ucraina 69
JP - Giappone 67
KR - Corea 62
BG - Bulgaria 56
FI - Finlandia 45
SC - Seychelles 42
CI - Costa d'Avorio 41
CH - Svizzera 29
AR - Argentina 27
JO - Giordania 26
TG - Togo 26
ZA - Sudafrica 25
CA - Canada 21
ID - Indonesia 20
PH - Filippine 19
PL - Polonia 18
TH - Thailandia 17
BD - Bangladesh 15
MX - Messico 13
PK - Pakistan 12
ES - Italia 11
IQ - Iraq 11
IR - Iran 11
BE - Belgio 10
AT - Austria 9
EE - Estonia 9
TR - Turchia 9
EC - Ecuador 7
TW - Taiwan 7
UZ - Uzbekistan 7
BH - Bahrain 6
CL - Cile 6
KE - Kenya 6
MY - Malesia 6
CO - Colombia 5
RO - Romania 5
SA - Arabia Saudita 5
NG - Nigeria 4
NP - Nepal 4
PY - Paraguay 4
EG - Egitto 3
GR - Grecia 3
LT - Lituania 3
PE - Perù 3
BA - Bosnia-Erzegovina 2
DO - Repubblica Dominicana 2
MA - Marocco 2
MD - Moldavia 2
OM - Oman 2
TN - Tunisia 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
AZ - Azerbaigian 1
BB - Barbados 1
BF - Burkina Faso 1
BW - Botswana 1
CG - Congo 1
CU - Cuba 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
ET - Etiopia 1
GT - Guatemala 1
IL - Israele 1
IS - Islanda 1
JM - Giamaica 1
KG - Kirghizistan 1
KZ - Kazakistan 1
MU - Mauritius 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
SK - Slovacchia (Repubblica Slovacca) 1
SR - Suriname 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
VE - Venezuela 1
Totale 8.151
Salva come PNG Salva come JPEG
Città #
Singapore 673
Hong Kong 336
Chandler 287
San Jose 284
Ashburn 267
Santa Clara 248
Ho Chi Minh City 221
Southend 203
Hanoi 187
Boardman 118
Fairfield 104
Beijing 102
Princeton 97
Hefei 95
Dublin 88
Los Angeles 57
Sofia 52
Ann Arbor 51
Tokyo 50
Wilmington 49
Houston 48
Lauterbourg 47
Seoul 46
Woodbridge 46
Berlin 43
Helsinki 43
Cambridge 42
Abidjan 41
Jacksonville 41
New York 39
Seattle 37
Frankfurt am Main 33
Da Nang 30
Haiphong 29
Bern 28
Guangzhou 27
Amman 26
Lomé 26
Buffalo 25
Milan 25
Bologna 24
Dong Ket 24
Falkenstein 24
Nanjing 23
Turin 18
Shanghai 17
Dallas 16
Padova 16
Westminster 16
Rome 15
Chicago 14
Redondo Beach 14
Warsaw 14
São Paulo 13
Bengaluru 12
Mumbai 12
Hải Dương 11
Boston 10
Brussels 10
Chennai 10
Jinan 10
London 10
Orem 10
Poplar 10
San Diego 10
Wuhan 10
Xi'an 10
Biên Hòa 9
Can Tho 9
Changsha 9
Düsseldorf 9
Hangzhou 9
Johannesburg 9
Nuremberg 9
Shijiazhuang 9
Yubileyny 9
Amsterdam 8
Columbus 8
Curitiba 8
Kyiv 8
Lahore 8
Montreal 8
Munich 8
Olalla 8
Vũng Tàu 8
Zhengzhou 8
Belo Horizonte 7
Denver 7
Mountain View 7
Mülheim 7
Nanchang 7
Shenyang 7
Shenzhen 7
Tianjin 7
Bangkok 6
Jakarta 6
Long Xuyen 6
Manila 6
Ninh Bình 6
Phoenix 6
Totale 4.927
Salva come PNG Salva come JPEG
Nome #
5-Aminosalicylic acid in patients with ulcerative colitis in remission: plasma levels after administration of a new rectal enema 266
Reversibility of GERD ultrastructural alterations and relief of symptoms after omeprazole treatment 252
5-Aminosalicylic acid suppositories in the management of ulcerative colitis 239
Erosions or not in GORD? The potential role of oesophageal cell proliferation 233
Effetti avversi gastrointestinali: farmaci anti-infiammatori non steroidei ed Helicobacter pylori 222
Effect of omeprazole on symptoms and ultrastructural esophageal damage in acid bile reflux 215
Epidemiologia dell’Infezione da Helicobacter pylori e Cancro gastrico non cardiale. Insegnamenti per il futuro. 205
Cell proliferation and ultrastructural changes of the duodenal mucosa of patients affected by familial adenomatous polyposis. 201
A Rapid Immunochromatographic Assay for Helicobacter pylori in Stool before and after Treatment 198
Effect of Proton Pump Inhibitors and Antacid Therapy on 13C-Urea Breath Tests and Stool Test for Helicobacter pylori Infection 196
Erosions or not in GERD? The potential role of esophageal cell kinetics 186
Italian guidelines for intestinal transplantation: potential candidates among the adult patients managed by a medical referral center for chronic intestinal failure. 175
Diagnosi dell’infezione da Helicobacter pylori 173
Diagnosi non invasiva e terapia per Helicobacter Pylori 172
The SF-36 instrument for the follow-up of health-related quality-of-life assessment of patients undergoing home parenteral nutrition for benign disease. 168
Peptic ulcer and Helicobacter pylori. 155
Three-year experience in clinical intestinal transplantation 152
Superoxide dismutase expression in gastric adenocarcinoma: a clinical biomarker in the development of cancer. 136
Effects of new fish oil derivative on fatty acid phospholipid-membrane pattern in a group of Crohn's disease patients 115
Long-term efficacy of bismuth carbomer enemas in patients with treatment-resistant chronic pouchitis 112
Changes in splanchnic hemodynamics in inflammatory bowel disease non-invasive assessment by doppler ultrasound flowmetry 105
Bioavailability of single and multiple doses of a new oral formulation of 5‐ASA in patients with inflammatory bowel disease and healthy volunteers 105
Retrograde colonic spread of a new mesalazine rectal enema in patients with distal ulcerative colitis 103
Respiratory burst of circulating polymorphonuclear leukocytes and plasma elastase levels in patients with inflammatory bowel disease in remission 102
5-Aminosalicylic acid as enemas or suppositories in distal ulcerative colitis? 101
Optimum dosage of 5-Aminosalicylic acid as rectal enemas in patients with active ulcerative colitis 101
Interleukin 1 in ulcerative colitis 101
Placebo-controlled trial of oral 5-ASA in relapse prevention of Crohn's disease 99
Scavenger effect of sulphasalazine (SASP), 5-aminosalicylic acid (5-ASA), and olsalazine (OAZ) (I) 97
Role of rectal formulations: Enemas 96
Enhanced mucosal interleukin-6 and -8 in Helicobacter pylori-positive dyspeptic patients 95
Macrophage subpopulations in pouchitis 95
Bronchopulmonary involvement in ulcerative colitis 92
Scavenger effect of sulfasalazine, 5-aminosalicylic acid, and olsalazine on superoxide radical generation 91
Short report: zinc sulphate supplementation corrects abnormal erythrocyte membrane long‐chain fatty acid composition in patients with Crohn's disease 90
Comparison of oral with rectal mesalazine in the treatment of ulcerative proctitis 90
Lack of effect of antineutrophil cytoplasmic antibodies associated with ulcerative colitis on superoxide anion production from neutrophils 89
Efficacy of 5-aminosalicylic acid enemas versus hydrocortisone enemas in ulcerative colitis 89
Topical treatment with 5-aminosalicylic in distal ulcerative colitis by using a new suppository preparation - A double-blind placebo controlled trial 88
Pentasa in maintenance treatment of ulcerative colitis 87
Intracolonic release of nitric oxide during trinitrobenzene sulfonic acid rat colitis 87
Interleukin 1 beta (IL-1 beta) release from fresh and cultured colonic mucosa in patients with ulcerative colitis (UC) 87
Requirements for the use of intestinal action antibiotics in the treatment of ulcerative colitis 86
Mucosal concentrations of interleukin-1β, interleukin-6, interleukin-8, and tumor necrosis factor-α in pelvic ileal pouches 83
Spread and distribution of 5-ASA colonic foam and 5-ASA enema in patients with ulcerative colitis 76
Systemic availability of 5-aminosalicylic acid: Comparison of delayed release and an azo-bond preparation 76
The clinical role of stool test (HpSA) in noninvasive diagnosis of Helicobacter pylori infection 70
Non-invasive analyses for the diagnosis of Helicobacter pylori infection. A critical review of the literature 70
Helicobacter pylori and diminished growth in children: Is it simply a marker of deprivation? 70
Rifaximin suspension for the eradication of helicobacter pylori 67
Helicobacter pylori in Patients with Gastric and Nongastric Cancer 64
A rapid, low-dose, 13C-urea tablet for the detection of Helicobacter pylori infection before and after treatment 62
Gastric retention of sucralfate gel and suspension in upper gastrointestinal diseases 59
Peptic ulcer and Helicobacter pylori: Update on testing and treatment 55
The clinical role of cytochrome P450 genotypes in Helicobacter pylori management 54
Folic acid supplementation and cell kinetics of rectal mucosa in patients with ulcerative colitis 54
Antimicrobial activity of esomeprazole versus omeprazole against Helicobacter pylori 52
Helicobacter pylori in Patients with Gastric and Nongastric Cancer 52
High eradication rates of Helicobacter pylori with a new sequential treatment 51
The clinical role of stool test (HpSA) in noninvasive diagnosis of Helicobacter pylori infection 51
High eradication rates of Helicobacter pylori with a new sequential treatment 50
Helicobacter pylori status, endoscopic findings, and serology in HIV-1-positive patients 41
Helicobacter pylori status, endoscopic findings, and serology in HIV-1-positive patients 41
A clinical study of gastric emptying and bioadhesitivity of two forms of sucralfate 41
Hypersensitivity of gastric parietal cells to selective H2-receptor stimulation in duodenal ulcer 40
Rectal cell proliferation and colon cancer risk in patients with hypergastrinaemia 40
Endoscopic findings in 288 asymptomatic blood donors according to high levels of IgG to helicobacter pylori 39
Review article: Diagnosis and treatment of Helicobacter: A 2002 updated review 38
Lipid peroxidation and antioxidant status in adults receiving lipid- based home parenteral nutrition 38
Helicobacter pylori, diagnosis and treatment after 10 years of its discovery 37
Review article: Invasive and non-invasive tests for Helicobacter pylori infection 37
Spectrotypic analysis of antibodies to Helicobacter pylori in patients with antral gastritis and duodenal ulcer 37
Therapeutics news on Helicobacter pylori and clarithromycin from Budapest, Wien and Helsinki 36
Clinical aspects of serology in the diagnosis of Helicobacter pylori infection 36
Diagnostic accuracy of a new rapid urease test (Pronto Dry) before and after treatment of Helicobacter pylori infection 35
Review article: Helicobacter pylori infection from pathogenesis to treatment - A critical reappraisal 35
Review article: Diagnosis of Helicobacter pylori infection 29
Susceptibility of Helicobacter pylori to Metronidazole 29
Clinical significance of helicobacter pylori seropositivity and seronegativity in asymptomatic blood donors 28
Routes of trasmission of Helicobacter pylori infection 28
Prospective screening of dyspeptic patients by Helicobacter pylori serology: A safe policy? 27
Anti-CagA reactivity in Helicobacter pylori-negative subjects: A comparison of three different methods 26
Optimal nutritional indexes in gastroenterology 26
A second-line anti-Helicobacter pylori therapy in patients with previously failed treatment [7] 25
Effect of Helicobacter pylori eradication on development of dyspeptic and reflux disease in healthy asymptomatic subjects 25
Source of Helicobacter pylori Infection 24
Clinical role of fecal antigen determination in the diagnosis of Helicobacter pylori infection 23
Circadian rhythm of gastric inhibitory polypeptide (GIP) in man 23
Symptoms and Helicobacter pylori: Any link [6] 22
Low levels of essential fatty acids in the red blood cell membrane phospholipid fraction of long-term home parenteral nutrition patients [1] 22
Prospective screening of dyspeptic patients by Helicobacter pylori serology: A safe policy? 21
Therapeutic news on Helicobacter pylori from Budapest and Wien 21
Diagnosis of Helicobacter pylori infection: Which is the best test? The stool test 21
Biliary surgery without the surgeon! 20
Comparison of urease tests for the diagnosis of Helicobacter pylori infection 20
Lactose Malabsorption in Adult Patients with Crohn's Disease 20
Treatment of symptom-free Helicobacter pylori-positive subjects 19
Helicobacter pylori: Diseases, tests and treatment 18
Therapeutic news on Helicobacter pylori from Budapest and Wien 18
Helicobacter pylori and other spiral organisms in gastroduodenal disease 17
Totale 8.186
Salva come PNG Salva come JPEG
Categoria #
all - tutte 26.735
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.735
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202176 0 0 0 0 0 0 0 0 0 15 14 47
2021/2022687 19 12 30 34 36 14 4 25 125 71 207 110
2022/20231.024 109 172 88 84 69 80 28 69 182 21 50 72
2023/2024444 96 66 30 60 32 83 12 23 3 23 7 9
2024/20251.795 59 189 131 100 402 88 130 69 27 135 55 410
2025/20263.492 296 308 344 287 404 208 279 262 844 260 0 0
Totale 8.308